nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—ABCB1—Mitomycin—urinary bladder cancer	0.069	0.324	CbGbCtD
Quetiapine—ADRA1B—vas deferens—urinary bladder cancer	0.0418	0.187	CbGeAlD
Quetiapine—CYP3A4—Thiotepa—urinary bladder cancer	0.0313	0.147	CbGbCtD
Quetiapine—HTR7—vas deferens—urinary bladder cancer	0.0243	0.109	CbGeAlD
Quetiapine—CYP3A5—Etoposide—urinary bladder cancer	0.0218	0.102	CbGbCtD
Quetiapine—ABCB1—Gemcitabine—urinary bladder cancer	0.0199	0.0933	CbGbCtD
Quetiapine—CHRM3—ureter—urinary bladder cancer	0.0196	0.0875	CbGeAlD
Quetiapine—ABCB1—Cisplatin—urinary bladder cancer	0.0144	0.0678	CbGbCtD
Quetiapine—ABCB1—Etoposide—urinary bladder cancer	0.0142	0.0666	CbGbCtD
Quetiapine—CHRM3—muscle of abdomen—urinary bladder cancer	0.0141	0.063	CbGeAlD
Quetiapine—ABCB1—Doxorubicin—urinary bladder cancer	0.00967	0.0454	CbGbCtD
Quetiapine—ABCB1—Methotrexate—urinary bladder cancer	0.00937	0.044	CbGbCtD
Quetiapine—CYP2D6—Doxorubicin—urinary bladder cancer	0.00912	0.0428	CbGbCtD
Quetiapine—CYP3A4—Etoposide—urinary bladder cancer	0.0085	0.0399	CbGbCtD
Quetiapine—CYP2C19—urine—urinary bladder cancer	0.00591	0.0264	CbGeAlD
Quetiapine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0058	0.0272	CbGbCtD
Quetiapine—HTR2A—urine—urinary bladder cancer	0.00378	0.0169	CbGeAlD
Quetiapine—ADRA1D—prostate gland—urinary bladder cancer	0.00365	0.0163	CbGeAlD
Quetiapine—H1F0—prostate gland—urinary bladder cancer	0.00352	0.0157	CbGeAlD
Quetiapine—CYP3A4—urine—urinary bladder cancer	0.0035	0.0156	CbGeAlD
Quetiapine—CYP2D6—urine—urinary bladder cancer	0.00344	0.0154	CbGeAlD
Quetiapine—CHRM5—epithelium—urinary bladder cancer	0.003	0.0134	CbGeAlD
Quetiapine—H1F0—seminal vesicle—urinary bladder cancer	0.00298	0.0133	CbGeAlD
Quetiapine—CHRM2—prostate gland—urinary bladder cancer	0.0028	0.0125	CbGeAlD
Quetiapine—ADRA1D—epithelium—urinary bladder cancer	0.00268	0.012	CbGeAlD
Quetiapine—CHRM1—prostate gland—urinary bladder cancer	0.00255	0.0114	CbGeAlD
Quetiapine—ADRA1B—renal system—urinary bladder cancer	0.00254	0.0114	CbGeAlD
Quetiapine—H1F0—smooth muscle tissue—urinary bladder cancer	0.00249	0.0111	CbGeAlD
Quetiapine—DRD5—female reproductive system—urinary bladder cancer	0.00249	0.0111	CbGeAlD
Quetiapine—ADRA1D—urethra—urinary bladder cancer	0.00244	0.0109	CbGeAlD
Quetiapine—H1F0—renal system—urinary bladder cancer	0.0024	0.0107	CbGeAlD
Quetiapine—H1F0—urethra—urinary bladder cancer	0.00236	0.0105	CbGeAlD
Quetiapine—CHRM3—prostate gland—urinary bladder cancer	0.00228	0.0102	CbGeAlD
Quetiapine—ADRA1A—prostate gland—urinary bladder cancer	0.0021	0.00937	CbGeAlD
Quetiapine—ADRA2C—prostate gland—urinary bladder cancer	0.002	0.00892	CbGeAlD
Quetiapine—ADRA1D—female reproductive system—urinary bladder cancer	0.00199	0.0089	CbGeAlD
Quetiapine—H1F0—female reproductive system—urinary bladder cancer	0.00192	0.00859	CbGeAlD
Quetiapine—H1F0—vagina—urinary bladder cancer	0.00174	0.00777	CbGeAlD
Quetiapine—ADRA2C—seminal vesicle—urinary bladder cancer	0.00169	0.00755	CbGeAlD
Quetiapine—CYP3A5—prostate gland—urinary bladder cancer	0.00167	0.00747	CbGeAlD
Quetiapine—HRH1—prostate gland—urinary bladder cancer	0.00162	0.00725	CbGeAlD
Quetiapine—CHRM3—smooth muscle tissue—urinary bladder cancer	0.00162	0.00722	CbGeAlD
Quetiapine—HTR7—epithelium—urinary bladder cancer	0.0016	0.00713	CbGeAlD
Quetiapine—ADRA2A—prostate gland—urinary bladder cancer	0.00159	0.00712	CbGeAlD
Quetiapine—CHRM3—renal system—urinary bladder cancer	0.00156	0.00695	CbGeAlD
Quetiapine—HTR1A—renal system—urinary bladder cancer	0.00155	0.00692	CbGeAlD
Quetiapine—ADRA1A—epithelium—urinary bladder cancer	0.00154	0.00688	CbGeAlD
Quetiapine—HTR7—smooth muscle tissue—urinary bladder cancer	0.00154	0.00687	CbGeAlD
Quetiapine—HTR1B—female reproductive system—urinary bladder cancer	0.00154	0.00687	CbGeAlD
Quetiapine—CHRM3—urethra—urinary bladder cancer	0.00153	0.00683	CbGeAlD
Quetiapine—HTR1D—female reproductive system—urinary bladder cancer	0.00149	0.00665	CbGeAlD
Quetiapine—HTR7—renal system—urinary bladder cancer	0.00148	0.00662	CbGeAlD
Quetiapine—HTR2C—female reproductive system—urinary bladder cancer	0.00148	0.00659	CbGeAlD
Quetiapine—ADRA1A—renal system—urinary bladder cancer	0.00143	0.00638	CbGeAlD
Quetiapine—CHRM1—female reproductive system—urinary bladder cancer	0.00139	0.00622	CbGeAlD
Quetiapine—ADRA2C—renal system—urinary bladder cancer	0.00136	0.00608	CbGeAlD
Quetiapine—ADRA2A—seminal vesicle—urinary bladder cancer	0.00135	0.00602	CbGeAlD
Quetiapine—ADRA2C—urethra—urinary bladder cancer	0.00134	0.00598	CbGeAlD
Quetiapine—CHRM3—female reproductive system—urinary bladder cancer	0.00125	0.00557	CbGeAlD
Quetiapine—HRH1—epithelium—urinary bladder cancer	0.00119	0.00533	CbGeAlD
Quetiapine—HTR7—female reproductive system—urinary bladder cancer	0.00119	0.0053	CbGeAlD
Quetiapine—HRH1—smooth muscle tissue—urinary bladder cancer	0.00115	0.00513	CbGeAlD
Quetiapine—CYP3A5—renal system—urinary bladder cancer	0.00114	0.00509	CbGeAlD
Quetiapine—H1F0—lymph node—urinary bladder cancer	0.00113	0.00502	CbGeAlD
Quetiapine—HRH1—urethra—urinary bladder cancer	0.00109	0.00485	CbGeAlD
Quetiapine—ADRA2A—urethra—urinary bladder cancer	0.00107	0.00477	CbGeAlD
Quetiapine—CYP2C19—vagina—urinary bladder cancer	0.00105	0.00468	CbGeAlD
Quetiapine—HTR2A—epithelium—urinary bladder cancer	0.000996	0.00445	CbGeAlD
Quetiapine—ADRA2C—vagina—urinary bladder cancer	0.000987	0.00441	CbGeAlD
Quetiapine—HTR2A—smooth muscle tissue—urinary bladder cancer	0.00096	0.00429	CbGeAlD
Quetiapine—HTR2A—renal system—urinary bladder cancer	0.000924	0.00413	CbGeAlD
Quetiapine—ABCB1—prostate gland—urinary bladder cancer	0.000888	0.00397	CbGeAlD
Quetiapine—HRH1—female reproductive system—urinary bladder cancer	0.000886	0.00396	CbGeAlD
Quetiapine—ADRA2A—female reproductive system—urinary bladder cancer	0.00087	0.00389	CbGeAlD
Quetiapine—CYP3A4—renal system—urinary bladder cancer	0.000855	0.00382	CbGeAlD
Quetiapine—CYP2D6—renal system—urinary bladder cancer	0.000842	0.00376	CbGeAlD
Quetiapine—CYP3A5—vagina—urinary bladder cancer	0.000826	0.00369	CbGeAlD
Quetiapine—HRH1—vagina—urinary bladder cancer	0.000801	0.00358	CbGeAlD
Quetiapine—ADRA2A—vagina—urinary bladder cancer	0.000787	0.00352	CbGeAlD
Quetiapine—ABCB1—seminal vesicle—urinary bladder cancer	0.000751	0.00336	CbGeAlD
Quetiapine—HTR2A—female reproductive system—urinary bladder cancer	0.00074	0.00331	CbGeAlD
Quetiapine—CYP3A4—female reproductive system—urinary bladder cancer	0.000685	0.00306	CbGeAlD
Quetiapine—CYP2D6—female reproductive system—urinary bladder cancer	0.000674	0.00301	CbGeAlD
Quetiapine—HTR2A—vagina—urinary bladder cancer	0.000669	0.00299	CbGeAlD
Quetiapine—ABCB1—epithelium—urinary bladder cancer	0.000653	0.00292	CbGeAlD
Quetiapine—ADRA2C—lymph node—urinary bladder cancer	0.000638	0.00285	CbGeAlD
Quetiapine—ABCB1—renal system—urinary bladder cancer	0.000606	0.0027	CbGeAlD
Quetiapine—ABCB1—urethra—urinary bladder cancer	0.000595	0.00266	CbGeAlD
Quetiapine—HRH1—lymph node—urinary bladder cancer	0.000518	0.00232	CbGeAlD
Quetiapine—ADRA2A—lymph node—urinary bladder cancer	0.000509	0.00227	CbGeAlD
Quetiapine—ABCB1—female reproductive system—urinary bladder cancer	0.000485	0.00217	CbGeAlD
Quetiapine—ABCB1—vagina—urinary bladder cancer	0.000439	0.00196	CbGeAlD
Quetiapine—ABCB1—lymph node—urinary bladder cancer	0.000284	0.00127	CbGeAlD
Quetiapine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000211	0.000454	CcSEcCtD
Quetiapine—Asthenia—Cisplatin—urinary bladder cancer	0.00021	0.000453	CcSEcCtD
Quetiapine—Pharyngitis—Epirubicin—urinary bladder cancer	0.00021	0.000453	CcSEcCtD
Quetiapine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00021	0.000452	CcSEcCtD
Quetiapine—Sweating—Doxorubicin—urinary bladder cancer	0.000209	0.000451	CcSEcCtD
Quetiapine—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000209	0.000451	CcSEcCtD
Quetiapine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000209	0.000449	CcSEcCtD
Quetiapine—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000208	0.000448	CcSEcCtD
Quetiapine—Urethral disorder—Epirubicin—urinary bladder cancer	0.000208	0.000447	CcSEcCtD
Quetiapine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000206	0.000445	CcSEcCtD
Quetiapine—Epistaxis—Doxorubicin—urinary bladder cancer	0.000206	0.000444	CcSEcCtD
Quetiapine—Angiopathy—Methotrexate—urinary bladder cancer	0.000205	0.000442	CcSEcCtD
Quetiapine—Sinusitis—Doxorubicin—urinary bladder cancer	0.000205	0.000441	CcSEcCtD
Quetiapine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000204	0.00044	CcSEcCtD
Quetiapine—Dizziness—Fluorouracil—urinary bladder cancer	0.000204	0.00044	CcSEcCtD
Quetiapine—Visual impairment—Epirubicin—urinary bladder cancer	0.000204	0.00044	CcSEcCtD
Quetiapine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000204	0.000439	CcSEcCtD
Quetiapine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000204	0.000439	CcSEcCtD
Quetiapine—Chills—Methotrexate—urinary bladder cancer	0.000203	0.000437	CcSEcCtD
Quetiapine—Diarrhoea—Cisplatin—urinary bladder cancer	0.0002	0.000432	CcSEcCtD
Quetiapine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.0002	0.000431	CcSEcCtD
Quetiapine—Vomiting—Gemcitabine—urinary bladder cancer	0.0002	0.000431	CcSEcCtD
Quetiapine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000199	0.00043	CcSEcCtD
Quetiapine—Mental disorder—Methotrexate—urinary bladder cancer	0.000198	0.000427	CcSEcCtD
Quetiapine—Rash—Gemcitabine—urinary bladder cancer	0.000198	0.000427	CcSEcCtD
Quetiapine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000198	0.000427	CcSEcCtD
Quetiapine—Eye disorder—Epirubicin—urinary bladder cancer	0.000198	0.000426	CcSEcCtD
Quetiapine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000198	0.000426	CcSEcCtD
Quetiapine—Tinnitus—Epirubicin—urinary bladder cancer	0.000197	0.000425	CcSEcCtD
Quetiapine—Malnutrition—Methotrexate—urinary bladder cancer	0.000197	0.000424	CcSEcCtD
Quetiapine—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000197	0.000424	CcSEcCtD
Quetiapine—Headache—Gemcitabine—urinary bladder cancer	0.000197	0.000424	CcSEcCtD
Quetiapine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000197	0.000423	CcSEcCtD
Quetiapine—Vomiting—Fluorouracil—urinary bladder cancer	0.000196	0.000423	CcSEcCtD
Quetiapine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000196	0.000423	CcSEcCtD
Quetiapine—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000196	0.000422	CcSEcCtD
Quetiapine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000196	0.000422	CcSEcCtD
Quetiapine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000195	0.00042	CcSEcCtD
Quetiapine—Rash—Fluorouracil—urinary bladder cancer	0.000195	0.00042	CcSEcCtD
Quetiapine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000195	0.000419	CcSEcCtD
Quetiapine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000194	0.000419	CcSEcCtD
Quetiapine—Headache—Fluorouracil—urinary bladder cancer	0.000194	0.000417	CcSEcCtD
Quetiapine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000193	0.000417	CcSEcCtD
Quetiapine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000193	0.000416	CcSEcCtD
Quetiapine—Dysgeusia—Methotrexate—urinary bladder cancer	0.000193	0.000416	CcSEcCtD
Quetiapine—Asthenia—Etoposide—urinary bladder cancer	0.000193	0.000415	CcSEcCtD
Quetiapine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000193	0.000415	CcSEcCtD
Quetiapine—Angiopathy—Epirubicin—urinary bladder cancer	0.000192	0.000414	CcSEcCtD
Quetiapine—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000192	0.000414	CcSEcCtD
Quetiapine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000191	0.000412	CcSEcCtD
Quetiapine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000191	0.000411	CcSEcCtD
Quetiapine—Back pain—Methotrexate—urinary bladder cancer	0.000191	0.000411	CcSEcCtD
Quetiapine—Chills—Epirubicin—urinary bladder cancer	0.00019	0.000409	CcSEcCtD
Quetiapine—Pruritus—Etoposide—urinary bladder cancer	0.00019	0.000409	CcSEcCtD
Quetiapine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000189	0.000407	CcSEcCtD
Quetiapine—Nausea—Gemcitabine—urinary bladder cancer	0.000187	0.000402	CcSEcCtD
Quetiapine—Vomiting—Cisplatin—urinary bladder cancer	0.000186	0.000401	CcSEcCtD
Quetiapine—Vision blurred—Methotrexate—urinary bladder cancer	0.000186	0.0004	CcSEcCtD
Quetiapine—Mental disorder—Epirubicin—urinary bladder cancer	0.000186	0.0004	CcSEcCtD
Quetiapine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000185	0.000399	CcSEcCtD
Quetiapine—Rash—Cisplatin—urinary bladder cancer	0.000185	0.000398	CcSEcCtD
Quetiapine—Dermatitis—Cisplatin—urinary bladder cancer	0.000185	0.000398	CcSEcCtD
Quetiapine—Malnutrition—Epirubicin—urinary bladder cancer	0.000184	0.000397	CcSEcCtD
Quetiapine—Diarrhoea—Etoposide—urinary bladder cancer	0.000184	0.000396	CcSEcCtD
Quetiapine—Nausea—Fluorouracil—urinary bladder cancer	0.000184	0.000396	CcSEcCtD
Quetiapine—Eye disorder—Doxorubicin—urinary bladder cancer	0.000183	0.000395	CcSEcCtD
Quetiapine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000183	0.000394	CcSEcCtD
Quetiapine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000183	0.000394	CcSEcCtD
Quetiapine—Anaemia—Methotrexate—urinary bladder cancer	0.000182	0.000392	CcSEcCtD
Quetiapine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000182	0.000392	CcSEcCtD
Quetiapine—Flatulence—Epirubicin—urinary bladder cancer	0.000182	0.000391	CcSEcCtD
Quetiapine—Tension—Epirubicin—urinary bladder cancer	0.000181	0.00039	CcSEcCtD
Quetiapine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000181	0.000389	CcSEcCtD
Quetiapine—Nervousness—Epirubicin—urinary bladder cancer	0.000179	0.000386	CcSEcCtD
Quetiapine—Back pain—Epirubicin—urinary bladder cancer	0.000178	0.000384	CcSEcCtD
Quetiapine—Angiopathy—Doxorubicin—urinary bladder cancer	0.000178	0.000383	CcSEcCtD
Quetiapine—Malaise—Methotrexate—urinary bladder cancer	0.000178	0.000383	CcSEcCtD
Quetiapine—Dizziness—Etoposide—urinary bladder cancer	0.000177	0.000382	CcSEcCtD
Quetiapine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000177	0.000382	CcSEcCtD
Quetiapine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000177	0.000381	CcSEcCtD
Quetiapine—Vertigo—Methotrexate—urinary bladder cancer	0.000177	0.000381	CcSEcCtD
Quetiapine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000177	0.00038	CcSEcCtD
Quetiapine—Leukopenia—Methotrexate—urinary bladder cancer	0.000176	0.00038	CcSEcCtD
Quetiapine—Chills—Doxorubicin—urinary bladder cancer	0.000176	0.000379	CcSEcCtD
Quetiapine—Nausea—Cisplatin—urinary bladder cancer	0.000174	0.000375	CcSEcCtD
Quetiapine—Vision blurred—Epirubicin—urinary bladder cancer	0.000174	0.000374	CcSEcCtD
Quetiapine—Cough—Methotrexate—urinary bladder cancer	0.000172	0.00037	CcSEcCtD
Quetiapine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000172	0.00037	CcSEcCtD
Quetiapine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000171	0.000369	CcSEcCtD
Quetiapine—Convulsion—Methotrexate—urinary bladder cancer	0.000171	0.000368	CcSEcCtD
Quetiapine—Vomiting—Etoposide—urinary bladder cancer	0.000171	0.000368	CcSEcCtD
Quetiapine—Malnutrition—Doxorubicin—urinary bladder cancer	0.000171	0.000368	CcSEcCtD
Quetiapine—Anaemia—Epirubicin—urinary bladder cancer	0.00017	0.000367	CcSEcCtD
Quetiapine—Agitation—Epirubicin—urinary bladder cancer	0.000169	0.000365	CcSEcCtD
Quetiapine—Rash—Etoposide—urinary bladder cancer	0.000169	0.000365	CcSEcCtD
Quetiapine—Dermatitis—Etoposide—urinary bladder cancer	0.000169	0.000364	CcSEcCtD
Quetiapine—Headache—Etoposide—urinary bladder cancer	0.000168	0.000362	CcSEcCtD
Quetiapine—Flatulence—Doxorubicin—urinary bladder cancer	0.000168	0.000362	CcSEcCtD
Quetiapine—Arthralgia—Methotrexate—urinary bladder cancer	0.000168	0.000361	CcSEcCtD
Quetiapine—Chest pain—Methotrexate—urinary bladder cancer	0.000168	0.000361	CcSEcCtD
Quetiapine—Myalgia—Methotrexate—urinary bladder cancer	0.000168	0.000361	CcSEcCtD
Quetiapine—Tension—Doxorubicin—urinary bladder cancer	0.000167	0.000361	CcSEcCtD
Quetiapine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000167	0.00036	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000167	0.000359	CcSEcCtD
Quetiapine—Malaise—Epirubicin—urinary bladder cancer	0.000166	0.000358	CcSEcCtD
Quetiapine—Discomfort—Methotrexate—urinary bladder cancer	0.000166	0.000357	CcSEcCtD
Quetiapine—Nervousness—Doxorubicin—urinary bladder cancer	0.000166	0.000357	CcSEcCtD
Quetiapine—Vertigo—Epirubicin—urinary bladder cancer	0.000166	0.000357	CcSEcCtD
Quetiapine—Syncope—Epirubicin—urinary bladder cancer	0.000165	0.000356	CcSEcCtD
Quetiapine—Leukopenia—Epirubicin—urinary bladder cancer	0.000165	0.000356	CcSEcCtD
Quetiapine—Back pain—Doxorubicin—urinary bladder cancer	0.000165	0.000355	CcSEcCtD
Quetiapine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000164	0.000353	CcSEcCtD
Quetiapine—Palpitations—Epirubicin—urinary bladder cancer	0.000163	0.000351	CcSEcCtD
Quetiapine—Confusional state—Methotrexate—urinary bladder cancer	0.000162	0.000349	CcSEcCtD
Quetiapine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000162	0.000349	CcSEcCtD
Quetiapine—Cough—Epirubicin—urinary bladder cancer	0.000161	0.000347	CcSEcCtD
Quetiapine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000161	0.000346	CcSEcCtD
Quetiapine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000161	0.000346	CcSEcCtD
Quetiapine—Convulsion—Epirubicin—urinary bladder cancer	0.00016	0.000344	CcSEcCtD
Quetiapine—Infection—Methotrexate—urinary bladder cancer	0.00016	0.000344	CcSEcCtD
Quetiapine—Nausea—Etoposide—urinary bladder cancer	0.000159	0.000344	CcSEcCtD
Quetiapine—Hypertension—Epirubicin—urinary bladder cancer	0.000159	0.000343	CcSEcCtD
Quetiapine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000158	0.000341	CcSEcCtD
Quetiapine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000158	0.00034	CcSEcCtD
Quetiapine—Anaemia—Doxorubicin—urinary bladder cancer	0.000158	0.00034	CcSEcCtD
Quetiapine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000157	0.000339	CcSEcCtD
Quetiapine—Chest pain—Epirubicin—urinary bladder cancer	0.000157	0.000338	CcSEcCtD
Quetiapine—Arthralgia—Epirubicin—urinary bladder cancer	0.000157	0.000338	CcSEcCtD
Quetiapine—Myalgia—Epirubicin—urinary bladder cancer	0.000157	0.000338	CcSEcCtD
Quetiapine—Agitation—Doxorubicin—urinary bladder cancer	0.000157	0.000338	CcSEcCtD
Quetiapine—Anxiety—Epirubicin—urinary bladder cancer	0.000156	0.000337	CcSEcCtD
Quetiapine—Skin disorder—Methotrexate—urinary bladder cancer	0.000156	0.000336	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000156	0.000336	CcSEcCtD
Quetiapine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000155	0.000335	CcSEcCtD
Quetiapine—Discomfort—Epirubicin—urinary bladder cancer	0.000155	0.000334	CcSEcCtD
Quetiapine—Malaise—Doxorubicin—urinary bladder cancer	0.000154	0.000331	CcSEcCtD
Quetiapine—Dry mouth—Epirubicin—urinary bladder cancer	0.000153	0.000331	CcSEcCtD
Quetiapine—Vertigo—Doxorubicin—urinary bladder cancer	0.000153	0.00033	CcSEcCtD
Quetiapine—Anorexia—Methotrexate—urinary bladder cancer	0.000153	0.00033	CcSEcCtD
Quetiapine—Syncope—Doxorubicin—urinary bladder cancer	0.000153	0.00033	CcSEcCtD
Quetiapine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000153	0.000329	CcSEcCtD
Quetiapine—Confusional state—Epirubicin—urinary bladder cancer	0.000152	0.000327	CcSEcCtD
Quetiapine—Palpitations—Doxorubicin—urinary bladder cancer	0.000151	0.000325	CcSEcCtD
Quetiapine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00015	0.000324	CcSEcCtD
Quetiapine—Hypotension—Methotrexate—urinary bladder cancer	0.00015	0.000324	CcSEcCtD
Quetiapine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00015	0.000323	CcSEcCtD
Quetiapine—Infection—Epirubicin—urinary bladder cancer	0.000149	0.000322	CcSEcCtD
Quetiapine—Cough—Doxorubicin—urinary bladder cancer	0.000149	0.000321	CcSEcCtD
Quetiapine—Shock—Epirubicin—urinary bladder cancer	0.000148	0.000319	CcSEcCtD
Quetiapine—Convulsion—Doxorubicin—urinary bladder cancer	0.000148	0.000318	CcSEcCtD
Quetiapine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000148	0.000318	CcSEcCtD
Quetiapine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000147	0.000317	CcSEcCtD
Quetiapine—Hypertension—Doxorubicin—urinary bladder cancer	0.000147	0.000317	CcSEcCtD
Quetiapine—Tachycardia—Epirubicin—urinary bladder cancer	0.000147	0.000316	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000146	0.000316	CcSEcCtD
Quetiapine—Skin disorder—Epirubicin—urinary bladder cancer	0.000146	0.000315	CcSEcCtD
Quetiapine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000145	0.000313	CcSEcCtD
Quetiapine—Insomnia—Methotrexate—urinary bladder cancer	0.000145	0.000313	CcSEcCtD
Quetiapine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000145	0.000313	CcSEcCtD
Quetiapine—Chest pain—Doxorubicin—urinary bladder cancer	0.000145	0.000313	CcSEcCtD
Quetiapine—Myalgia—Doxorubicin—urinary bladder cancer	0.000145	0.000313	CcSEcCtD
Quetiapine—Anxiety—Doxorubicin—urinary bladder cancer	0.000145	0.000312	CcSEcCtD
Quetiapine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000144	0.000311	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000144	0.000311	CcSEcCtD
Quetiapine—Discomfort—Doxorubicin—urinary bladder cancer	0.000143	0.000309	CcSEcCtD
Quetiapine—Anorexia—Epirubicin—urinary bladder cancer	0.000143	0.000309	CcSEcCtD
Quetiapine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000143	0.000309	CcSEcCtD
Quetiapine—Somnolence—Methotrexate—urinary bladder cancer	0.000143	0.000308	CcSEcCtD
Quetiapine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000142	0.000306	CcSEcCtD
Quetiapine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000141	0.000305	CcSEcCtD
Quetiapine—Hypotension—Epirubicin—urinary bladder cancer	0.000141	0.000303	CcSEcCtD
Quetiapine—Confusional state—Doxorubicin—urinary bladder cancer	0.00014	0.000302	CcSEcCtD
Quetiapine—Decreased appetite—Methotrexate—urinary bladder cancer	0.00014	0.000301	CcSEcCtD
Quetiapine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000139	0.0003	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000139	0.000299	CcSEcCtD
Quetiapine—Fatigue—Methotrexate—urinary bladder cancer	0.000139	0.000299	CcSEcCtD
Quetiapine—Infection—Doxorubicin—urinary bladder cancer	0.000138	0.000298	CcSEcCtD
Quetiapine—Pain—Methotrexate—urinary bladder cancer	0.000137	0.000296	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000137	0.000295	CcSEcCtD
Quetiapine—Shock—Doxorubicin—urinary bladder cancer	0.000137	0.000295	CcSEcCtD
Quetiapine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000137	0.000294	CcSEcCtD
Quetiapine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000136	0.000294	CcSEcCtD
Quetiapine—Insomnia—Epirubicin—urinary bladder cancer	0.000136	0.000293	CcSEcCtD
Quetiapine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000136	0.000293	CcSEcCtD
Quetiapine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000135	0.000291	CcSEcCtD
Quetiapine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000135	0.000291	CcSEcCtD
Quetiapine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000135	0.00029	CcSEcCtD
Quetiapine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000134	0.000289	CcSEcCtD
Quetiapine—Somnolence—Epirubicin—urinary bladder cancer	0.000134	0.000288	CcSEcCtD
Quetiapine—Anorexia—Doxorubicin—urinary bladder cancer	0.000133	0.000286	CcSEcCtD
Quetiapine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000132	0.000285	CcSEcCtD
Quetiapine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000132	0.000285	CcSEcCtD
Quetiapine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000131	0.000283	CcSEcCtD
Quetiapine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000131	0.000282	CcSEcCtD
Quetiapine—Hypotension—Doxorubicin—urinary bladder cancer	0.00013	0.00028	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00013	0.00028	CcSEcCtD
Quetiapine—Fatigue—Epirubicin—urinary bladder cancer	0.00013	0.000279	CcSEcCtD
Quetiapine—Pain—Epirubicin—urinary bladder cancer	0.000129	0.000277	CcSEcCtD
Quetiapine—Constipation—Epirubicin—urinary bladder cancer	0.000129	0.000277	CcSEcCtD
Quetiapine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000127	0.000274	CcSEcCtD
Quetiapine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000127	0.000274	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000127	0.000273	CcSEcCtD
Quetiapine—Insomnia—Doxorubicin—urinary bladder cancer	0.000126	0.000271	CcSEcCtD
Quetiapine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000125	0.000269	CcSEcCtD
Quetiapine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000124	0.000267	CcSEcCtD
Quetiapine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000124	0.000267	CcSEcCtD
Quetiapine—Somnolence—Doxorubicin—urinary bladder cancer	0.000124	0.000267	CcSEcCtD
Quetiapine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000123	0.000265	CcSEcCtD
Quetiapine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000123	0.000264	CcSEcCtD
Quetiapine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000121	0.000261	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00012	0.000259	CcSEcCtD
Quetiapine—Fatigue—Doxorubicin—urinary bladder cancer	0.00012	0.000259	CcSEcCtD
Quetiapine—Pain—Doxorubicin—urinary bladder cancer	0.000119	0.000256	CcSEcCtD
Quetiapine—Constipation—Doxorubicin—urinary bladder cancer	0.000119	0.000256	CcSEcCtD
Quetiapine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000119	0.000256	CcSEcCtD
Quetiapine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000119	0.000256	CcSEcCtD
Quetiapine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000118	0.000255	CcSEcCtD
Quetiapine—Asthenia—Methotrexate—urinary bladder cancer	0.000115	0.000249	CcSEcCtD
Quetiapine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000115	0.000247	CcSEcCtD
Quetiapine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000114	0.000245	CcSEcCtD
Quetiapine—Pruritus—Methotrexate—urinary bladder cancer	0.000114	0.000245	CcSEcCtD
Quetiapine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000111	0.000239	CcSEcCtD
Quetiapine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.00011	0.000237	CcSEcCtD
Quetiapine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00011	0.000237	CcSEcCtD
Quetiapine—Diarrhoea—Methotrexate—urinary bladder cancer	0.00011	0.000237	CcSEcCtD
Quetiapine—Asthenia—Epirubicin—urinary bladder cancer	0.000108	0.000233	CcSEcCtD
Quetiapine—Pruritus—Epirubicin—urinary bladder cancer	0.000106	0.000229	CcSEcCtD
Quetiapine—Dizziness—Methotrexate—urinary bladder cancer	0.000106	0.000229	CcSEcCtD
Quetiapine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000103	0.000222	CcSEcCtD
Quetiapine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000103	0.000221	CcSEcCtD
Quetiapine—Vomiting—Methotrexate—urinary bladder cancer	0.000102	0.00022	CcSEcCtD
Quetiapine—Rash—Methotrexate—urinary bladder cancer	0.000101	0.000218	CcSEcCtD
Quetiapine—Dermatitis—Methotrexate—urinary bladder cancer	0.000101	0.000218	CcSEcCtD
Quetiapine—Headache—Methotrexate—urinary bladder cancer	0.000101	0.000217	CcSEcCtD
Quetiapine—Asthenia—Doxorubicin—urinary bladder cancer	9.99e-05	0.000215	CcSEcCtD
Quetiapine—Dizziness—Epirubicin—urinary bladder cancer	9.95e-05	0.000214	CcSEcCtD
Quetiapine—Pruritus—Doxorubicin—urinary bladder cancer	9.85e-05	0.000212	CcSEcCtD
Quetiapine—Vomiting—Epirubicin—urinary bladder cancer	9.56e-05	0.000206	CcSEcCtD
Quetiapine—Nausea—Methotrexate—urinary bladder cancer	9.55e-05	0.000206	CcSEcCtD
Quetiapine—Diarrhoea—Doxorubicin—urinary bladder cancer	9.52e-05	0.000205	CcSEcCtD
Quetiapine—Rash—Epirubicin—urinary bladder cancer	9.49e-05	0.000204	CcSEcCtD
Quetiapine—Dermatitis—Epirubicin—urinary bladder cancer	9.48e-05	0.000204	CcSEcCtD
Quetiapine—Headache—Epirubicin—urinary bladder cancer	9.42e-05	0.000203	CcSEcCtD
Quetiapine—Dizziness—Doxorubicin—urinary bladder cancer	9.2e-05	0.000198	CcSEcCtD
Quetiapine—Nausea—Epirubicin—urinary bladder cancer	8.94e-05	0.000193	CcSEcCtD
Quetiapine—Vomiting—Doxorubicin—urinary bladder cancer	8.85e-05	0.000191	CcSEcCtD
Quetiapine—Rash—Doxorubicin—urinary bladder cancer	8.78e-05	0.000189	CcSEcCtD
Quetiapine—Dermatitis—Doxorubicin—urinary bladder cancer	8.77e-05	0.000189	CcSEcCtD
Quetiapine—Headache—Doxorubicin—urinary bladder cancer	8.72e-05	0.000188	CcSEcCtD
Quetiapine—Nausea—Doxorubicin—urinary bladder cancer	8.27e-05	0.000178	CcSEcCtD
Quetiapine—ADRA2B—Signaling Pathways—CDKN1A—urinary bladder cancer	8.33e-06	8.42e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—KRAS—urinary bladder cancer	8.33e-06	8.41e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—KRAS—urinary bladder cancer	8.32e-06	8.4e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CCND1—urinary bladder cancer	8.31e-06	8.4e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—PTEN—urinary bladder cancer	8.31e-06	8.4e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—EGFR—urinary bladder cancer	8.31e-06	8.4e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CCND1—urinary bladder cancer	8.27e-06	8.36e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—ERBB2—urinary bladder cancer	8.26e-06	8.35e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—KRAS—urinary bladder cancer	8.26e-06	8.35e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL2—urinary bladder cancer	8.25e-06	8.34e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PTEN—urinary bladder cancer	8.22e-06	8.31e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—KRAS—urinary bladder cancer	8.2e-06	8.29e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—MYC—urinary bladder cancer	8.14e-06	8.23e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—ERBB2—urinary bladder cancer	8.13e-06	8.22e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL2—urinary bladder cancer	8.12e-06	8.21e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—ERBB2—urinary bladder cancer	8.11e-06	8.2e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—KRAS—urinary bladder cancer	8.09e-06	8.18e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—ERBB2—urinary bladder cancer	8.09e-06	8.17e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MMP9—urinary bladder cancer	8.07e-06	8.16e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—ERBB2—urinary bladder cancer	8.06e-06	8.15e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CCND1—urinary bladder cancer	8.05e-06	8.13e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CDKN1A—urinary bladder cancer	8.04e-06	8.13e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MMP9—urinary bladder cancer	8.03e-06	8.12e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—PTEN—urinary bladder cancer	8.03e-06	8.11e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CDKN1A—urinary bladder cancer	8e-06	8.09e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—RHOA—urinary bladder cancer	7.99e-06	8.07e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—PTEN—urinary bladder cancer	7.98e-06	8.07e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—ERBB2—urinary bladder cancer	7.98e-06	8.07e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—ERBB2—urinary bladder cancer	7.96e-06	8.05e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—EGFR—urinary bladder cancer	7.96e-06	8.05e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—KRAS—urinary bladder cancer	7.96e-06	8.04e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EP300—urinary bladder cancer	7.93e-06	8.01e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	7.93e-06	8.01e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CCND1—urinary bladder cancer	7.92e-06	8e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—KRAS—urinary bladder cancer	7.85e-06	7.94e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—EP300—urinary bladder cancer	7.84e-06	7.92e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CXCL8—urinary bladder cancer	7.84e-06	7.92e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MMP9—urinary bladder cancer	7.81e-06	7.89e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	7.79e-06	7.87e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—HRAS—urinary bladder cancer	7.79e-06	7.87e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CDKN1A—urinary bladder cancer	7.78e-06	7.87e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—PTEN—urinary bladder cancer	7.77e-06	7.85e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—MYC—urinary bladder cancer	7.76e-06	7.84e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CXCL8—urinary bladder cancer	7.71e-06	7.79e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—SRC—urinary bladder cancer	7.71e-06	7.79e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CXCL8—urinary bladder cancer	7.69e-06	7.77e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MMP9—urinary bladder cancer	7.69e-06	7.77e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CXCL8—urinary bladder cancer	7.67e-06	7.75e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—HRAS—urinary bladder cancer	7.66e-06	7.74e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CDKN1A—urinary bladder cancer	7.66e-06	7.74e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EP300—urinary bladder cancer	7.65e-06	7.73e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—MYC—urinary bladder cancer	7.65e-06	7.73e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—MYC—urinary bladder cancer	7.65e-06	7.73e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CXCL8—urinary bladder cancer	7.64e-06	7.73e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—HRAS—urinary bladder cancer	7.64e-06	7.72e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—PTEN—urinary bladder cancer	7.64e-06	7.72e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—HRAS—urinary bladder cancer	7.62e-06	7.7e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EP300—urinary bladder cancer	7.61e-06	7.69e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PPARG—urinary bladder cancer	7.6e-06	7.68e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—HRAS—urinary bladder cancer	7.6e-06	7.68e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—EGFR—urinary bladder cancer	7.59e-06	7.67e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CXCL8—urinary bladder cancer	7.57e-06	7.65e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CXCL8—urinary bladder cancer	7.55e-06	7.63e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PTEN—urinary bladder cancer	7.54e-06	7.62e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—HRAS—urinary bladder cancer	7.52e-06	7.6e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—KRAS—urinary bladder cancer	7.52e-06	7.6e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—HRAS—urinary bladder cancer	7.5e-06	7.58e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL2—urinary bladder cancer	7.49e-06	7.57e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—EGFR—urinary bladder cancer	7.49e-06	7.56e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—EGFR—urinary bladder cancer	7.49e-06	7.56e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	7.48e-06	7.56e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—SRC—urinary bladder cancer	7.44e-06	7.52e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EP300—urinary bladder cancer	7.41e-06	7.48e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—SRC—urinary bladder cancer	7.4e-06	7.48e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TP53—urinary bladder cancer	7.4e-06	7.48e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—ERBB2—urinary bladder cancer	7.4e-06	7.48e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TP53—urinary bladder cancer	7.39e-06	7.47e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL2—urinary bladder cancer	7.37e-06	7.45e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL2—urinary bladder cancer	7.35e-06	7.43e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TP53—urinary bladder cancer	7.34e-06	7.42e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL2—urinary bladder cancer	7.33e-06	7.41e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL2—urinary bladder cancer	7.31e-06	7.38e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	7.3e-06	7.38e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CCND1—urinary bladder cancer	7.3e-06	7.38e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EP300—urinary bladder cancer	7.29e-06	7.37e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL2—urinary bladder cancer	7.23e-06	7.31e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL2—urinary bladder cancer	7.22e-06	7.29e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—SRC—urinary bladder cancer	7.2e-06	7.28e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—EP300—urinary bladder cancer	7.19e-06	7.27e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TP53—urinary bladder cancer	7.19e-06	7.27e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CCND1—urinary bladder cancer	7.18e-06	7.26e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CCND1—urinary bladder cancer	7.17e-06	7.24e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—KRAS—urinary bladder cancer	7.17e-06	7.24e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	7.17e-06	7.24e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CCND1—urinary bladder cancer	7.14e-06	7.22e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CCND1—urinary bladder cancer	7.12e-06	7.2e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	7.11e-06	7.19e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—SRC—urinary bladder cancer	7.09e-06	7.16e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MMP9—urinary bladder cancer	7.09e-06	7.16e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—HRAS—urinary bladder cancer	7.08e-06	7.15e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TP53—urinary bladder cancer	7.08e-06	7.15e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—KRAS—urinary bladder cancer	7.07e-06	7.15e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—KRAS—urinary bladder cancer	7.07e-06	7.15e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—HRAS—urinary bladder cancer	7.07e-06	7.14e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CDKN1A—urinary bladder cancer	7.06e-06	7.14e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CCND1—urinary bladder cancer	7.05e-06	7.13e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PTEN—urinary bladder cancer	7.05e-06	7.12e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CCND1—urinary bladder cancer	7.03e-06	7.11e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—HRAS—urinary bladder cancer	7.02e-06	7.1e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CXCL8—urinary bladder cancer	7.01e-06	7.09e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TP53—urinary bladder cancer	6.98e-06	7.05e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MMP9—urinary bladder cancer	6.97e-06	7.05e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—HRAS—urinary bladder cancer	6.97e-06	7.04e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MMP9—urinary bladder cancer	6.96e-06	7.03e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CDKN1A—urinary bladder cancer	6.95e-06	7.02e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MMP9—urinary bladder cancer	6.94e-06	7.01e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CDKN1A—urinary bladder cancer	6.93e-06	7.01e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PTEN—urinary bladder cancer	6.93e-06	7.01e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PTEN—urinary bladder cancer	6.92e-06	6.99e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MMP9—urinary bladder cancer	6.91e-06	6.99e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	6.91e-06	6.99e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	6.91e-06	6.98e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MYC—urinary bladder cancer	6.91e-06	6.98e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PTEN—urinary bladder cancer	6.9e-06	6.97e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CDKN1A—urinary bladder cancer	6.89e-06	6.96e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	6.88e-06	6.96e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—HRAS—urinary bladder cancer	6.88e-06	6.95e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PTEN—urinary bladder cancer	6.87e-06	6.95e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MMP9—urinary bladder cancer	6.85e-06	6.92e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MMP9—urinary bladder cancer	6.83e-06	6.9e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CDKN1A—urinary bladder cancer	6.82e-06	6.89e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PTEN—urinary bladder cancer	6.81e-06	6.88e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CDKN1A—urinary bladder cancer	6.8e-06	6.88e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PTEN—urinary bladder cancer	6.79e-06	6.86e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—HRAS—urinary bladder cancer	6.77e-06	6.84e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EGFR—urinary bladder cancer	6.76e-06	6.83e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EP300—urinary bladder cancer	6.72e-06	6.79e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL2—urinary bladder cancer	6.7e-06	6.77e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—urinary bladder cancer	6.68e-06	6.75e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—HRAS—urinary bladder cancer	6.68e-06	6.75e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MYC—urinary bladder cancer	6.67e-06	6.74e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MYC—urinary bladder cancer	6.64e-06	6.71e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	6.61e-06	6.68e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EP300—urinary bladder cancer	6.61e-06	6.68e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EP300—urinary bladder cancer	6.6e-06	6.67e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—EP300—urinary bladder cancer	6.59e-06	6.66e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EP300—urinary bladder cancer	6.58e-06	6.65e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EP300—urinary bladder cancer	6.56e-06	6.62e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	6.54e-06	6.61e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	6.54e-06	6.61e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCND1—urinary bladder cancer	6.54e-06	6.6e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—SRC—urinary bladder cancer	6.53e-06	6.6e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EGFR—urinary bladder cancer	6.52e-06	6.59e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EP300—urinary bladder cancer	6.49e-06	6.56e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EGFR—urinary bladder cancer	6.49e-06	6.56e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EP300—urinary bladder cancer	6.47e-06	6.54e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MYC—urinary bladder cancer	6.45e-06	6.52e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—SRC—urinary bladder cancer	6.43e-06	6.5e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—SRC—urinary bladder cancer	6.42e-06	6.48e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—SRC—urinary bladder cancer	6.4e-06	6.46e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—HRAS—urinary bladder cancer	6.39e-06	6.46e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—KRAS—urinary bladder cancer	6.38e-06	6.45e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—SRC—urinary bladder cancer	6.37e-06	6.44e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—urinary bladder cancer	6.37e-06	6.44e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MYC—urinary bladder cancer	6.35e-06	6.42e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MMP9—urinary bladder cancer	6.34e-06	6.41e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CDKN1A—urinary bladder cancer	6.32e-06	6.39e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—SRC—urinary bladder cancer	6.31e-06	6.38e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EGFR—urinary bladder cancer	6.31e-06	6.38e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PTEN—urinary bladder cancer	6.31e-06	6.37e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—SRC—urinary bladder cancer	6.3e-06	6.36e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—urinary bladder cancer	6.28e-06	6.35e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—urinary bladder cancer	6.28e-06	6.35e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	6.26e-06	6.33e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EGFR—urinary bladder cancer	6.21e-06	6.28e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—KRAS—urinary bladder cancer	6.16e-06	6.23e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	6.15e-06	6.21e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—KRAS—urinary bladder cancer	6.13e-06	6.2e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	6.13e-06	6.19e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—HRAS—urinary bladder cancer	6.09e-06	6.16e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EP300—urinary bladder cancer	6.02e-06	6.08e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—HRAS—urinary bladder cancer	6.01e-06	6.07e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—HRAS—urinary bladder cancer	6.01e-06	6.07e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	5.98e-06	6.04e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—KRAS—urinary bladder cancer	5.96e-06	6.03e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—KRAS—urinary bladder cancer	5.87e-06	5.93e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MYC—urinary bladder cancer	5.86e-06	5.92e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—SRC—urinary bladder cancer	5.85e-06	5.91e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	5.78e-06	5.84e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MYC—urinary bladder cancer	5.76e-06	5.82e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MYC—urinary bladder cancer	5.75e-06	5.81e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MYC—urinary bladder cancer	5.73e-06	5.79e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EGFR—urinary bladder cancer	5.73e-06	5.79e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MYC—urinary bladder cancer	5.71e-06	5.77e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—urinary bladder cancer	5.67e-06	5.73e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MYC—urinary bladder cancer	5.66e-06	5.72e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MYC—urinary bladder cancer	5.64e-06	5.7e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	5.64e-06	5.7e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EGFR—urinary bladder cancer	5.64e-06	5.7e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EGFR—urinary bladder cancer	5.62e-06	5.68e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EGFR—urinary bladder cancer	5.61e-06	5.66e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EGFR—urinary bladder cancer	5.59e-06	5.65e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EGFR—urinary bladder cancer	5.53e-06	5.59e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EGFR—urinary bladder cancer	5.52e-06	5.58e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—urinary bladder cancer	5.48e-06	5.53e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—urinary bladder cancer	5.45e-06	5.51e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—HRAS—urinary bladder cancer	5.43e-06	5.48e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—KRAS—urinary bladder cancer	5.41e-06	5.47e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	5.34e-06	5.4e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—KRAS—urinary bladder cancer	5.32e-06	5.38e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—KRAS—urinary bladder cancer	5.31e-06	5.37e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—urinary bladder cancer	5.3e-06	5.36e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—KRAS—urinary bladder cancer	5.3e-06	5.35e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—KRAS—urinary bladder cancer	5.28e-06	5.33e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MYC—urinary bladder cancer	5.24e-06	5.3e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—HRAS—urinary bladder cancer	5.24e-06	5.29e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—KRAS—urinary bladder cancer	5.23e-06	5.28e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTEN—urinary bladder cancer	5.22e-06	5.27e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—urinary bladder cancer	5.22e-06	5.27e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—KRAS—urinary bladder cancer	5.21e-06	5.27e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—HRAS—urinary bladder cancer	5.21e-06	5.27e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EGFR—urinary bladder cancer	5.13e-06	5.18e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—EP300—urinary bladder cancer	5.1e-06	5.15e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—HRAS—urinary bladder cancer	5.07e-06	5.12e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—HRAS—urinary bladder cancer	4.99e-06	5.04e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—EP300—urinary bladder cancer	4.97e-06	5.03e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	4.92e-06	4.97e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—KRAS—urinary bladder cancer	4.84e-06	4.89e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—urinary bladder cancer	4.81e-06	4.86e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—urinary bladder cancer	4.73e-06	4.78e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—urinary bladder cancer	4.72e-06	4.77e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—urinary bladder cancer	4.71e-06	4.76e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—urinary bladder cancer	4.69e-06	4.74e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—EP300—urinary bladder cancer	4.69e-06	4.74e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	4.68e-06	4.73e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—urinary bladder cancer	4.65e-06	4.69e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—urinary bladder cancer	4.63e-06	4.68e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—HRAS—urinary bladder cancer	4.6e-06	4.65e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—HRAS—urinary bladder cancer	4.53e-06	4.57e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—HRAS—urinary bladder cancer	4.52e-06	4.56e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—HRAS—urinary bladder cancer	4.5e-06	4.55e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.5e-06	4.55e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—HRAS—urinary bladder cancer	4.49e-06	4.53e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—HRAS—urinary bladder cancer	4.44e-06	4.49e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—HRAS—urinary bladder cancer	4.43e-06	4.48e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—urinary bladder cancer	4.3e-06	4.35e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—HRAS—urinary bladder cancer	4.12e-06	4.16e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.69e-06	3.72e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.21e-06	3.25e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.06e-06	3.1e-05	CbGpPWpGaD
